Profile: Murli Krishna Pharma Private Ltd. is a drug delivery systems (DDS) company that provides a range of effective solutions to optimize the delivery of pharmaceutical products. Our products include anti-ulcerative, anti-fungal, immuno suppressants, clarithromycin, and orlistat pellets. Our anti-ulcerative products include omeprazole, lansoprazole, esomeprazole magnesium, pantoprazole, mesalazine, and esomeprazole pellets. Our immuno suppressants are tacrolimus pellets, tacrolimus, sirrolimus (rapamycin) pellets, rapamycin, mycophenolate mofetil pellets, and mycophenolate mofitil. We manufacture formulations based on specialized coating techniques. We supply semi-finished forms of anti-ulcerants for the regulatory as well as the non-regulatory market. The molecules tend to be sensitive to stomach acid. The formulation is designed so that the drug is released in the small intestine. Omeprazole is a widely used proton pump inhibitor that is used in the treatment of peptic ulcers. The product is offered as a semi-finished formulation in a pelletized form. The API is manufactured under a strict control, with stringent specifications on the impurity profile. The polymers used are specifically chosen and are non-infringing. The pellets are offered in the strengths of 9.0%, 8.5% and 7.5%. The product can also be offered in a pellet size suitable for use in a suspension.